Haohai Life Science: Controlling shareholder Jiang Wei fined 14.6292 million yuan by the CSRC.

Haohai Life Science announced that Jiang Wei, one of the company's controlling shareholders and actual controllers, received an "Administrative Penalty Decision" issued by the China Securities Regulatory Commission for insider trading and recommending others to buy or sell securities. The China Securities Regulatory Commission decided to confiscate his illegal gains of 4.7097 million yuan and impose a fine of 14.6292 million yuan. This penalty is unrelated to the company and will not have a significant impact on the company's daily operations, business, or finances.